Healthou-Recovery Food
  

NEWS




TEL:+1855 51 HELLO(43556)
ADD:237COTE VERTU,#33563
        ST-LAURENT,QUEBEC,CANADA,
        H4N1C8
        IN US BY VITALABS INC.
Healthou_Protective effects of octacosanol on 6-hydroxydopamine-induced Parkinsonism in rats via regulation of ProNGF and NGF signaling

Tao Wang1, Yan-yong Liu1, Xin Wang1, Nan Yang1, Hai-bo Zhu2 and Ping-ping Zuo1

  1. 1Department of Pharmacology, Institute of Basic Medical Sciences, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100005, China
  2. 2Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine Affiliated Ministry of Education, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China

Correspondence: Ping-ping Zuo, E-mail pingping_zuo@126.com; Hai-bo Zhu,zhuhaibo@imm.ac.cn

Received 7 March 2010; Accepted 13 May 2010; Published online 28 June 2010.

Abstract

Aim:

 

To investigate the protective effects of octacosanol in 6-hydroxydopamine-induced Parkinsonian rats and find whether octacosanol has effects on pro nerve growth factor (pro-NGF), NGF and the downstream effector proteins.

Methods:

 

Behavioral tests, enzymatic assay, tyrosine hydroxylase immunohistochemistry, TUNEL and Western blot were used to investigate the effects of octacosanol in this rat model of PD.

Results:

 

Oral administration of octacosanol (35–70 mg/kg, po for 14 d) significantly improved the behavioral impairments in rats induced by 6-OHDA and dose-dependently preserved the free radical scavenging capability of the striatum. Octacosanol treatment also effectively ameliorated morphological appearances of TH-positive neuronal cells in nigrostriatal systems and decreased the apoptotic cells induced by 6-OHDA in striatum. In addition, octacosanol strikingly blocked the 6-OHDA-induced increased expression of proNGF-p75NTR-sortilin death signaling complex and its downstream effector proteins. Meantime, octacosanol prevented the decreased levels of NGF, its receptors TrkA and p-Akt which together mediated the cell survival pathway.

Conclusion:

 

The findings implicated that the anti-parkinsonism effects afforded by octacosanol might be mediated by its neuro-microenvironment improving potency through retrieving the ratios of proNGF:NGF and the respective receptors p75NTR:TrkA in vivo. Due to its excellent tolerability and non-toxicity, octacosanol may be a promising agent for PD treatment.

Keywords: 

Parkinson's disease; oxidative stress; proNGF; nerve growth factor; neuroprotection; apoptosis; octacosanol

Abbreviations: 

6-OHDA, 6-hydroxydopamine; AD, Alzheimer's disease; BSA, bovine serum albumin; CMC, carboxymethylcellulose sodium; CAT, catalase; DA, dopamine; DAB, 3,3′-diaminobenzidine; GSH-Px, glutathione peroxidase; JNK, Jun kinase; L-dopa, levodopa; MDA, malondialdehyde; NGF, nerve growth factor; Ocs, Octacosanol; PBS, phosphate buffered saline; PD, Parkinson's disease; ProNGF, precursor of nerve growth factor; prot., protein; ROS, reactive oxygen species; SN, substantia nigra; SOD, superoxide dismutase; TH, tyrosine hydroxylase; TUNEL, Terminal deoxynucleotidyl transferase-mediated dUTP Nick End Labeling assay

from source:http://www.nature.com/aps/journal/v31/n7/abs/aps201069a.html


CONTACT US | SECURITY AUTHENTICATION | SITE MAP
TEL:+1 855 51 HELLO(43556)
ADD:237COTE VERTU,#33563 ST-LAURENT,QUEBEC,CANADA,
H4N1C8 IN US BY VITALABS INC.

There statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose,treat,cure,or prevent any disease.